Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04994379
Other study ID # Tongue Motor Cortex
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2021
Est. completion date October 2021

Study information

Verified date August 2021
Source University of Messina
Contact Abed Hadipour Lakmehsari, PhD
Phone 090 371 0722
Email ahadipourlakmehsari@unime.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized double-blind sham controlled systematic investigation to understand the importance of the brain region that controls the tongue and the submental muscle region on perceived appetite. The results of this study can have clinical implications for a phenomenon called hyperphagia.


Description:

After explaning all the procedure and the scientific aims of the project to participants and completing the informed consent form, each participant will be randomly asked to take part in the experiment while fasting for at least 6 hours or completely sated, to enable an investigation of the role of the basic level of hunger on the effects of brain stimulation on subjective appetite. Different intensities of stimulation (1 mA, 1.5 mA, and sham) will be used in three separate groups, to which participants will be randomly assigned, in a double-blind manner.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date October 2021
Est. primary completion date September 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Normal weight, based on the Body Mass Index (BMI) - Males and females between 18 and 35 Exclusion Criteria: - Use of psychoactive drugs - Presence of metal implants in the brain, skull, scalp or neck - Use of pacemaker - Neurological or psychiatric pathologies - History of severe head injury - Pregnancy - Clinical obesity based on BMI

Study Design


Related Conditions & MeSH terms


Intervention

Device:
1 mA tDCS
One session with stimulation intensity of 1 mA.
1.5 mA tDCS
One session with stimulation intensity of 1.5 mA.
Sham tDCS
One session of sham stimulation.

Locations

Country Name City State
Italy University of Messina Messina Sicily

Sponsors (1)

Lead Sponsor Collaborator
University of Messina

Country where clinical trial is conducted

Italy, 

References & Publications (2)

Vicario CM, Rafal RD, Borgomaneri S, Paracampo R, Kritikos A, Avenanti A. Pictures of disgusting foods and disgusted facial expressions suppress the tongue motor cortex. Soc Cogn Affect Neurosci. 2017 Feb 1;12(2):352-362. doi: 10.1093/scan/nsw129. — View Citation

Vicario CM, Salehinejad MA, Mosayebi-Samani M, Maezawa H, Avenanti A, Nitsche MA. Transcranial direct current stimulation over the tongue motor cortex reduces appetite in healthy humans. Brain Stimul. 2020 Jul - Aug;13(4):1121-1123. doi: 10.1016/j.brs.2020.05.008. Epub 2020 May 12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the subjective rating of appetite A visual analogue scale (VAS; from 0 meaning not hungry at all, to 100 meaning extremely hungry), will be used to record the perceived level of hunger before and after the stimulation to enable evaluation of the effects of stimulation on perceived appetite. Baseline measurement in the begninning of the experiment before stimulation versus post stimulation, exactly after the stimulation protocol has finished (with an approximate time interval of 1 hour)
Secondary Change in excitability of the submental muscle region in primary motor cortex Recording motor evoked potentials from the area of the submental region of the motor cortex in addition to a control site (APB muscle), to allow for comparisons of the amplitude of MEPs before and after stimulation to draw conclusions about the effect of stimulation and its contribution to the potential behavioral modulations of tDCS Baseline measurement in the begninning of the experiment before stimulation versus post stimulation, exactly after the stimulation protocol has finished (with an approximate time interval of 1 hour)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1